E-LIB Suche - Ergebnisse für: Abrisqueta Costa, Pablo

1

Determinacions del perfil genètic de les malalties neoplàst..:

Abrisqueta Costa, Pablo ; Bellosillo, Beatriu ; Bosch Albareda, Francesc...
Abrisqueta P, Bellosillo B, Bosch F, Briones J, Climent F, Colomer D, et. al. Determinacions del perfil genètic de les malalties neoplàstiques hematològiques. Barcelona: Servei Català de la Salut; 2022.. , 2022

Link: https://hdl.handle.net/1..

2

Determinacions del perfil genètic de les malalties neoplàst..:

Abrisqueta Costa, Pablo ; Bellosillo, Beatriu ; Bosch Albareda, Francesc...
Abrisqueta P, Bellosillo B, Bosch F, Briones J, Climent F, Colomer D, et. al. Determinacions del perfil genètic de les malalties neoplàstiques hematològiques. Barcelona: Servei Català de la Salut; 2023.. , 2022

Link: https://hdl.handle.net/1..

3

Detection of early seeding of Richter transformation in chr..:

Royo, Romina ; Massoni-Badosa, Ramon ; Playa-Albinyana, Heribert...
Nature Medicine;28. , 2022

Link: https://hdl.handle.net/1..

4

Long-term outcomes from the Phase II L-MIND study of tafasi..:

Duell, Johannes ; Maddocks, Kami J ; González-Barca, Eva...
Haematologica;106(9). , 2021

Link: https://hdl.handle.net/1..

5

Determinacions del perfil genètic de les malalties neoplàst..:

Abrisqueta Costa, Pablo ; Bellosillo, Beatriu ; Bosch Albareda, Francesc...
Abrisqueta P, Bellosillo B, Bosch F, Briones J, Climent F, Colomer D, et. al. Determinacions del perfil genètic de les malalties neoplàstiques hematològiques. Barcelona: Servei Català de la Salu; 2021.. , 2021

Link: http://hdl.handle.net/11..

6

Immunological and genetic kinetics from diagnosis to clinic..:

Jiménez Bernal, Isabel ; Tazón Vega, Bárbara ; Abrisqueta Costa, Pablo...
Biomarker Research;9. , 2021

Link: https://hdl.handle.net/1..

7

Molecular and functional profiling identifies therapeutical..:

Frontzek, Fabian ; Staiger, Annette M ; Zapukhlyak, Myroslav...
Nature Communications;12. , 2021

Link: https://hdl.handle.net/1..

8

Real-world evidence of tisagenlecleucel for the treatment o..:

Iacoboni García-Calvo, Gloria ; Martinez-Cibrian, Nuria ; Bailén, Rebeca...
Cancer Medicine;10(10). , 2021

Link: https://hdl.handle.net/1..

9

Expanding the Diversity at the C-4 Position of Pyrido[2,3-d..:

Masip, Victor ; Lirio, Ángel ; López-Huertas, Albert...
Pharmaceuticals;14(12). , 2021

Link: https://hdl.handle.net/1..

10

ICO-ICS Praxi per al tractament de la leucèmia limfàtica cr..:

Abrisqueta Costa, Pablo ; do-Nascimento-Ferreira, Jannilson ; Farriols Danes, Anna Maria...
ICO-ICSPraxi;. , 2020

Link: https://hdl.handle.net/1..

11

Clinical characteristics and outcome of SARS-CoV-2 infectio..:

Muntañola, Ana ; Hernández‑Rivas, José Ángel ; Alonso, Rosalía...
Experimental Hematology & Oncology;9. , 2020

Link: https://hdl.handle.net/1..

12

Repolarization of tumor infiltrating macrophages and increa..:

Jiménez Bernal, Isabel ; Carabia Juberó, Júlia ; Bobillo Varela, Sabela...
Journal of Neuro-Oncology;149(1). , 2020

Link: https://hdl.handle.net/1..

13

ICO-ICS Praxi per al tractament mèdic i amb irradiació del ..:

Abrisqueta Costa, Pablo ; Auñón-Sanz, Carme ; Escoda-Teigell, Lourdes...
ICO-ICSPraxi;. , 2019

Link: https://hdl.handle.net/1..

14

PHASE 1/2A CLINICAL TRIAL OF BI‐1206, A MONOCLONAL ANTIBODY..:

Jerkeman, M. ; Costa, P. Abrisqueta ; Hagberg, H. E....
Hematological Oncology. 41 (2023) S2 - p. 835-836 , 2023

Link: https://doi.org/10.1002/..

15

Real-World Evidence on the Clinical Characteristics and Man..:

Loscertales, Javier ; Abrisqueta-Costa, Pau ; Gutierrez, Antonio...
Cancers. 15 (2023) 16 - p. 4047 , 2023

Link: https://doi.org/10.3390/..